Indiana

  Drug Litigation.
HOME ABOUT US FAQ'S RESOURCES CONTACT US FREE CASE REVIEW
July 20, 2010
Drug-Litigation
             
 
Selecting an attorney for legal cases is a very important decision. Please enter your information below to receive a Free Consultation from an attorney in your area:
 
Zip Code:   
 

Drug Litigation News

 

Office of Safe and Drug-Free Schools Convenes First Advisory Committee Meeting

Mental health and wellness experts, education leaders, law and drug-enforcement officials, a criminal judge and juvenile justice advocates from around the country came together Monday and Tuesday, June 12-13, in Washington, D.C., for their first meeting as members of the newly formed Safe and Drug-Free Schools and Communities Advisory Committee. The committee, appointed by U.S. Secretary of Education Margaret Spellings, is charged with evaluating three areas: the Office of Safe and Drug-Free Schools and Communities: State Grants program, Persistently Dangerous Schools and the Unsafe School Choice Option, and requirements for data under No Child Left Behind. "Students need a safe place to learn, and the Safe and Drug-Free Schools and Communities Advisory Committee will play a vital role as we move forward in ensuring that our students have safe and drug-free schools," Secretary Spellings said.

The committee, chaired by David Long, superintendent of Riverside County Public Schools in Riverside, Calif., consists of 11 expert panelists from across the country and eight ex-officio members. Members serve staggered terms, ranging from one to three years, in order to retain an experienced core of members. Approximately 12 additional meetings will take place between now and June 30, 2007, when the committee is to submit a written report of its findings to the Secretary. Once the report is completed, members will continue to meet to discuss issues relating to safe and drug-free schools. "This committee, which is made up of passionate citizens from across the country who have high levels of expertise and years of experience in safe schools and crisis planning and mental health research, will address questions, have lively discussions and ultimately submit a report to the Secretary with our findings," Chairman Long said. "And we are excited about the process."

While Monday's meeting included an overview of the various programs within the Office of Safe and Drug-Free Schools, on Tuesday, the committee also voted on the dates for its next two meetings and discussed prioritizing and streamlining issues within the three major categories on which they are to report to the Secretary. Members also decided to solicit the help of focus groups, which would consist of experts in the field, to assist with recommendations to the Secretary. No Child Left Behind authorizes the committee and the Federal Advisory Committee Act governs it. As mandated by its charter, the Safe and Drug-Free Schools and Communities Advisory Committee will announce all of its meetings, which are open to the public, in the Federal Register.

Contact our Indiana Drug Litigation Lawyer Now!

 

 
Did You Know?    
 
 
Drug companies spend more on marketing than R&D
The top 10 drug companies spent nearly three times more on marketing, public relations and administration than they did on research and development.

 


  Newsroom  
 


News about Drug Litigation cases in Indiana and nationwide:

Boca Medical Products Issues Recall of Insulin Syringe Product
 Boca Medical Products, Inc., of Coral Springs, Florida is initiating a recall of 3984 boxes of Ultilet Insulin Syringe 30g 1/2cc product lot ...
Read more >


Office of Safe and Drug-Free Schools Convenes First Advisory Committee Meeting
Office of Safe and Drug-Free Schools Convenes First Advisory Committee Meeting

Mental health and wellness experts, educati...

Read more >


Pending Generic Drug Applications
If a patent is listed in the "Orange Book," an applicant seeking approval for an ANDA must submit a certification to the patent. Even an applicant ...
Read more >


More Drug Litigation News >

 
 

Drug Litigation Terms

 


Today's Terms

Strength

Definition:
The strength of a drug product tells how much of the active ingredient is present in each dosage.

Discontinued Drug

Definition:
A discontinued drug is a drug product that has been removed from the market in the United States for reasons other than safety or effectiveness.

Product Number

Definition:
A product number is assigned to each drug product associated with an NDA (New Drug Application). If a drug product is available in multiple strengths, there are multiple product numbers.

More Drug Litigation Terms >

 

Drug Litigation Resources

 


Search Drug Litigation resources in our resource center:

More Resources >

 

Drug Litigation Hot Topics

 


Topics Related to Drug Litigation:

  • Adverse Effects
  • Prescription Drugs
  • Over the Counter Drugs
  • Drug Recalls
  • Dosage Errors
  • Drug Company Liability
  • Drug Company Negligence
  • More Drug Litigation Topics >

    Indiana Drug Litigation Attorney

     
    If you live in the following cities and need an Drug Litigation attorney you should contact our Drug Litigation Attorney as soon as possible:

    • Bloomington
    • Brownsburg
    • Carmel
    • Columbus
    • Connersville
    • Crawfordsville
    • Crown Point
    • East Chicago
    • Elkhart
    • Evansville
    • Fishers
    • Fort Wayne
    • Franklin
    • Goshen
    • Granger
    • Greenfield
    • Greenwood
    • Hobart
    • Huntington
    • Indianapolis
    • Jeffersonville
    • Kokomo
    • La Porte
    • Lafayette
    • Logansport
    • Marion
    • Martinsville
    • Merrillville
    • Michigan City
    • Mishawaka
    • Muncie
    • New Albany
    • New Castle
    • Newburgh
    • Noblesville
    • Peru
    • Plainfield
    • Portage
    • Richmond
    • Seymour
    • Shelbyville
    • South Bend
    • Terre Haute
    • Valparaiso
    • Vincennes
    • West Lafayette
     


    Legal Disclaimers
    All attorney listings are a paid attorney advertisement, and do not in any way constitute a referral or endorsement by an approved or authorized lawyer referral service. The information provided on Indiana Drug Litigation.com is not intended to be legal advice, but merely conveys general information related to legal issues commonly encountered. Your access to and use of this website is subject to additional Terms and Conditions.

    Local Professional? Generate new business today
    Call 866-227-9356 or contact a sales rep


    This site is part of the LawFirms.com Network
    ©2010 ExpertHub, wholly owned subsidiary of MoxyMedia, Inc.